23 listings

All Pharmacies for Sale

Every listing on the marketplace — 23 in total from 3 brokers. Last refreshed 2026-09-03.

Specialty Pharmacy
Texas
New
American HealthCare Capital is pleased to introduce a highly profitable specialty pharmacy for sale in Texas. This well-established company has a long-standing presence and outstanding reputation within the local communities they serve. The specialty pharmacy focuses on Rheumatology, Dermatology, G.I. diseases, Hypercholesterolemia, Viral Hepatitis, and Osteoporosis. Although they have focused primarily on serving Texas thus far, they are licensed in a total of 31 states, which could be a source of major growth. The pharmacy accepts all major payers, including Medicare, Medicaid, and private insurance. They have been able to achieve rapid growth within the last few years, with gross revenues of around $22 million in 2017 and $31 million in 2018. They are projecting gross revenues of $36 million in 2019 with an adjusted EBITDA of $1.5 million (4.7%) and an average script count of 1,000 per month. There is a full complement of staff that is expected to stay on post-acquisition. The sellers would like to pursue other business ventures but will assist during a transitional period as needed. The asking price for this opportunity is $12 Million plus the cost of inventory.
Asking price
$12,000,000
Annual revenue
$31,000,000
Listed by American HealthCare Capital (PRIME exits)
Specialty Pharmacy with Compounding
Florida
New
American HealthCare Capital is pleased to present a 340b pharmacy providing Specialty, Retail, and Compounding medications to patients throughout the state of Florida. The pharmacy has been in business since 2013 and has been growing steadily over the past four years. Their medication therapies have been focused on Dermatology, Crohn’s/GI, Hepatitis, HIV/Aids, Multiple Sclerosis, Oncology, Rheumatology, Ophthalmology, and Transplant. In recent months there has been tremendous growth into other therapies, such as autoimmune. The specialty pharmacy revenue and patient growth is bolstered by the implementation of proprietary software built on the platform of PioneerRX. Their software allows them to track the entire patient continuum and ensure therapeutic compliance with detailed documentation. The data they generate is proprietary, some of which they sell back to drug manufacturers. The company’s payer mix is 97% Medicare and Medicaid and 3% Cash. Gross revenues have shown consistent growth over the years. In 2017, gross revenues exceeded their projections for the year at $52,800,000, with an adjusted EBITDA of $1,914,000. They are expecting gross revenues to grow 20% in 2018. The current owners have decided to step away from the business to address personal issues, but are willing to stay involved to ensure a smooth transition and future growth of the company. The entire staff, including an experienced Pharmacist-in-Charge are expected to stay on with the new ownership. The asking price for this opportunity is $9.75 Million plus inventory.
Asking price
$9,750,000
Annual revenue
$53,000,000
Listed by American HealthCare Capital (PRIME exits)
Independent Pharmacy
Louisiana
New
The pharmacy is contracted with all major insurance. Their current payer mix is 40% Medicaid, 20% Commercial Insurance, 15% Medicare, 15% Cash, and 10% other. The pharmacy has more than doubled its gross revenue over the past two years, generating $3,156,664 in 2022 and $7,317,427 in 2023 with an adjusted EBITDA of $1,166,796. In 2024, they anticipate reaching $12 million in gross revenue with an adjusted EBITDA margin in the 15% range.
Asking price
$6,000,000
Annual revenue
$12,000,000
Listed by American HealthCare Capital (PRIME exits)
Independent Pharmacy
California
New
American Healthcare Capital is pleased to introduce a Medicare certified Retail Pharmacy for sale with five (5) locations. They are strategically positioned within affluent communities and have two locations adjacent to prominent hospitals and medical centers. The company has a storied brand which has serviced Southern California under the same ownership for nearly 40 years. In 2017, the company generated $15.2 Million in revenue and in 2018, the company generated roughly $14.2 Million in revenue. All key staff are expected to stay on and the seller is willing to assist through the transition. The asking price for the opportunity is $5 million, plus the cost of inventory. If you would like to learn more, please contact us for a Confidentiality Agreement that will allow us to share more detailed information with you.
Asking price
$5,000,000
Annual revenue
$14,200,000
Listed by American HealthCare Capital (PRIME exits)
Long-Term Care Pharmacy
Pennsylvania
New
PRIME exits and American HealthCare Capital are pleased to introduce a Long Term Care Pharmacy for sale in Pennsylvania and Maryland. Established over 40 years ago, the pharmacy has 4 locations. They have solid contracts with SNF, ALF, and CCRC beds, and many of those accounts have been serviced for years. They currently serve nearly 3,300 beds.
Asking price
$3,000,000
Annual revenue
$16,000,000
Listed by American HealthCare Capital (PRIME exits)
Long-Term Care Pharmacy
Texas
New
American HealthCare Capital is pleased to introduce a Closed Door Specialty pharmacy for sale in the Dallas, Texas area. This well-established pharmacy focuses on Developmentally Disabled pediatric patients. They service patients throughout the state of Texas. The Pharmacy’s business is 100% Medicaid reimbursement. Payments are weekly with a DSO of no more than 9 days. Through August of 2017, the Pharmacy had gross revenues of $7,347,000 with a run rate of $11,000,000 through the end of the year. In 2016, gross revenue was $11,880,000. The drop in revenue began in May 2016 when Medicaid reduced its reimbursement, resulting in a decrease of approximately $80,000/month. Regardless, the Pharmacy net profit remains in the black, with an expected Adjusted EBITDA of $450,000 (4%) for 2017. Beyond Texas, there is a growing market for pharmacies focused on heavily disabled children. Ownership will assist through a transition period, and the CEO/Pharmacist in Charge is willing to stay on in an executive capacity. The asking price for this opportunity is $2.75 Million, plus the cost of inventory, which is estimated at $200,000.
Asking price
$2,750,000
Annual revenue
$11,000,000
Listed by American HealthCare Capital (PRIME exits)
Independent Pharmacy
Texas
New
PRIME exits and American HealthCare Capital are pleased to exclusively introduce a retail pharmacy for sale in northwest Texas. The pharmacy has been in business over a decade. They are strategically located in a shopping center with other medical businesses.
Asking price
$2,600,000
Annual revenue
$15,000,000
Listed by American HealthCare Capital (PRIME exits)
Independent Pharmacy
Florida
New
Company Overview American HealthCare Capital is pleased to introduce a retail pharmacy business for sale headquartered in Central Florida. This long-standing pharmacy has been proudly serving the local community for decades. At present, they average 300 prescriptions per day consisting of 50% new prescriptions and 50% refills. Financial Overview The retail pharmacy business for sale in Central Florida has seen growth over the past few years. They grew from gross revenue of $5.5 million in 2020 to $6.6 million in 2021 with an EBITDA of $500,000. Based on results from the first half of the year, 2022 is in line with 2021 with respect to both revenue and EBITDA. Staffing Overview All the staff in this Central Florida pharmacy is expected to stay on under new ownership, including 2 Registered Pharmacists, 3 Certified Pharmacy Techs, and 5 Cashiers. Asking Price The asking price for this pharmacy for sale in Florida is $2.1 million.
Asking price
$2,100,000
Annual revenue
$6,600,000
Listed by American HealthCare Capital (PRIME exits)
Independent Pharmacy
Ohio
New
American HealthCare Capital is pleased to introduce an Independent Retail Pharmacy for sale in Northern Ohio. The pharmacy has been in business for 14 years. They are strategically situated within a Medical office building. The pharmacy’s payer mix is 93% Medicare, 5% Medicaid, 1% Insurance, and 1% Cash. The pharmacy revenue was $4,794,876 in 2016 with an adjusted EBITDA of $108,000, and they are expected to do the same in 2017. They currently dispense 1715 scripts per week with an average ticket of $60 per script. There are 30% new and 70% refill prescriptions per week. The owners are willing to accommodate a transitional period as needed. The remaining staff is available to stay on with a new owner. The asking price for this opportunity is $2 Million, plus the cost of inventory.
Asking price
$2,000,000
Annual revenue
$4,800,000
Listed by American HealthCare Capital (PRIME exits)
Infusion Pharmacy
Nevada
New
PRIME exits and American HealthCare Capital are pleased to introduce an Infusion Pharmacy business for sale in Las Vegas, Nevada. The pharmacy provides Home Infusion and has 3 Infusion chairs. The facility includes a 797-compliant clean room. This pharmacy for sale in Nevada has contracts with a number of commercial payers, and they are Medicare certified for Part B to provide DME. Gross revenues have grown consistently since the company’s inception. They are currently on track to reach almost $2 million in 2021, and they are profitable. The staff is expected to stay on, including 2 Pharmacists. The owners will accommodate a transitional period as well. The asking price for this business for sale in Las Vegas, Nevada is $1.1 Million, plus inventory.
Asking price
$1,100,000
Annual revenue
$2,000,000
Listed by American HealthCare Capital (PRIME exits)
Mail-Order Pharmacy with Compounding
Texas
New
American HealthCare Capital is pleased to introduce a retail pharmacy headquartered in Southeast Texas and Florida. The business generates approximately 99% of its revenue from dispensing diabetic supplies to patients nationwide. The business operates a traditional brick and mortar pharmacy in Texas and a marketing and order validation facility in Florida. The pharmacy has full licensure in most states. Operations could easily be expanded into other states by obtaining additional Pharmacy licenses, which would generate additional revenue. They accept all 3rd party insurance carriers and Part D Plans. Gross revenues are expected to reach $2 Million by the end of 2018 with the majority of the sales coming from high margin diabetic supplies. The Gross Margin is approximately 60% with net income of approximately 12%. This opportunity is an excellent launching point for an entity looking to quickly grow a specialty, retail, compounding , or a mail order pharmacy operation. It would also be an excellent add on to an existing Pharmacy and would greatly assist in increasing gross profit margins in most Pharmacy settings. The seller is motivated and would like to focus on other business ventures, but the rest of the staff, including the Pharmacist in Charge, will stay on with a new owner. The asking price for this opportunity is $1 Million.
Asking price
$1,000,000
Annual revenue
$2,000,000
Listed by American HealthCare Capital (PRIME exits)
Specialty Pharmacy
Florida
New
American HealthCare Capital is proud to introduce a full-service pharmacy located in Florida, offering the following specialty medications: dermatology, fertility, gastroenterology, hepatitis C, rheumatology, oncology, organ transplant, pain management and urology. They were a traditional retail pharmacy until their URAC accreditation in 2020, which expanded their focus and opportunity to drive dramatic future growth. Shipping to all 50 states and leveraging McKesson Specialty Supply Chain, they are capable of 300%-500% annual growth. This opportunity does not include any of the existing accounts. The sellers are in the process of moving their current accounts to their other pharmacy, so this transaction will be for the purchase of the existing retail and specialty pharmacy, its URAC certifications for specialty in all 50 states, their mail order licenses in 50 states, and their contracts with all the large and smaller pharmaceutical distribution and supply companies. The pharmacy employs 2 pharmacists, one of whom is an experienced specialty pharmacist, and 3 Pharmacy Technicians. They are all willing to stay under new ownership. The asking price for this opportunity is $1 million.
Asking price
$1,000,000
Listed by American HealthCare Capital (PRIME exits)
Long-Term Care Pharmacy
New Jersey
New
American HealthCare Capital is pleased to introduce a start-up pharmacy opportunity located in New Jersey. The Pharmacy license was established in January 2016. The license allows for retail, specialty, long term care, and infusion pharmacy dispensing throughout New Jersey. In addition, they are licensed in 40 non-resident states. The pharmacy license is not currently in operation, making this a great opportunity for a pharmacy/pharmacist wanting the flexibility of a start-up operation. The seller is willing to assist during the change of license ownership process. Asking price for this opportunity is $325,000.
Asking price
$325,000
Listed by American HealthCare Capital (PRIME exits)
Long-Term Care Pharmacy
Texas
New
American HealthCare Capital is pleased to introduce a Long Term Care Pharmacy for sale in Houston, Texas. The pharmacy has been in business since 2013 and they are licensed as a Community Independent Pharmacy. They focus on serving I/DD population care facilities. The company’s sole payer is Medicaid/Managed Medicaid. The company has contracts to service 118 beds in a number of group homes and foster homes in the surrounding area. The company is currently dispensing an average of 1,080 scripts per month. Gross revenues were over $1 million in 2018 with a Gross Profit Margin of 19%, and the company expects to see an increase in 2019. The seller would like to focus on other ventures but expects the core staff to stay on, including the Pharmacist in Charge and Pharmacy Technician. The asking price for this opportunity is $200,000 plus the cost of inventory.
Asking price
$200,000
Annual revenue
$1,000,000
Listed by American HealthCare Capital (PRIME exits)
Long-Term Care Pharmacy with Compounding
Texas
New
American HealthCare Capital is pleased to introduce a new Home Infusion Pharmacy for sale in Texas. The company is licensed by the Texas State Board of Pharmacy as a Community Pharmacy Compounding Sterile Preparations Class A-S Pharmacy. It is also considered a Closed Door, Specialty Pharmacy. Their license allows for the community dispensing of oral medications, as well as for patients to come into the pharmacy for Infusion Therapy Treatments, i.e. Infusion Suites. In the state of Texas, the pharmacy license can be transferred anywhere within the state. The home infusion pharmacy for sale is equipped with a Certified Clean Room with an ISO 8 AnteRoom, ISO 7 Buffer Room, and an ISO 5 Certified Laminar Flow Hood. Thus far, the pharmacy has not generated any revenue. They have recently received approval for accreditation/DMEPOS with ACHC to provide billing of enteral pumps and supplies, external infusion pumps and supplies, parenteral equipment and supplies, and parenteral nutrients. They have received their Medicare billing number and have the following statuses with Managed Care Contracts: out of network with BCBSTX, pending in-network contracts with BCBSTX, and letters of intent with Aetna and Humana. The owner and Pharmacist in Charge are available to assist during a transitional period. The asking price for this business for sale in Texas is $100,000.
Asking price
$100,000
Listed by American HealthCare Capital (PRIME exits)
Long-Term Care Pharmacy with Compounding
Texas
New
Offered Through Affiliate Partner Central Texas Pharmacy Retail Pharmacy for sale in central Texas. This pharmacy filled 64,853 prescriptions and generated $4,997,700 in sales in 2025. Owner runs this store on a semi-absentee basis and just oversees the operation but does not work pharmacist shifts at the store. This pharmacy has been a pillar of the community for over 60 years. Located in a modern freestanding 3,000 square foot building (owned by the proprietor) the pharmacy has a drive-thru window and provides both delivery and charge accounts with some long-term care services. The store had retail pharmacy gross profit of $737,535 with an average prescription price of $74.95 in 2025. The pharmacy currently does not compound prescriptions but has space available to build a compounding lab. The store also provides a nice assortment of OTC and gift merchandise. Insurance contracts are established and the licenses are in order with the Board of Pharmacy and DEA. This is great opportunity for both a semi-absentee owner or an owner operator who wants to own and operate the business. << Return to Listings Inquire on this Business Listing ID: ABMD-26055385-40 Location: Central Texas Typ
Asking price
930,000
Annual revenue
4,997,000
Listed by Hayslip & Zost Pharmacy Brokers (Advanced Business Brokers)
Long-Term Care Pharmacy
California
New
Offered Through Affiliate Partner Pharmacy for Sale – South Orange County, CA Retail & Long Term Care Pharmacy for sale in Orange County. This pharmacy fills 1,700 prescriptions per week and did $1,830,000 in sales in 2025 and on pace to do similar numbers in 2026. Owner runs this store on a semi absentee basis and just oversees the operation but does not work pharmacist shifts at the store. This pharmacy has been in operation for 12 years and as located in a small medical plaza. The pharmacy has a very low cost per prescription average due to the nature of the LTC business, which is mainly drug and alcohol rehab centers. 90% of the business is drug and alcohol Long Term Care and the remaining 10% is retail. The pharmacy had in an incredible gross profit margin of 60% in 2025. Only $745,000 was spent on drugs on $1,830,000 in sales! A new owner who knew how to cut labor efficiently would increase the net profit of the pharmacy substantially. Rent is $4,000 a month including NNN at this 1,500 sq. ft. store. All insurance contracts are in place and the license is clean with the Board of Pharmacy and DEA. The owner believes that all employees would stay after the transition to a new o
Asking price
1,300,000
Annual revenue
1,830,000
Listed by Hayslip & Zost Pharmacy Brokers (Advanced Business Brokers)
Specialty Pharmacy
Florida
New
Extremely profitable and well established specialty pharmacy in Florida. This pharmacy has annual sales of $17.3 Million and fills over 30,000 prescriptions per year with approximately $400,000 in inventory. Net discretionary income to owner in 2025 after being fully staffed was $2.13 Million. All major PBM contracts as well as direct manufacturer contracts and clean record.
Annual revenue
17.3 Million
Listed by Pharmacy Consulting Broker Services (PCBS)
Independent Pharmacy
Arkansas
New
Historic and profitable community pharmacy in Arkansas. 2025 annual sales of $1.76 Million and filling over 28,000 prescriptions per year with an estimated inventory of $110,000. Easy to operate and great hours. Income to owner-operator is over $300,000 per year. Clean licenses and contracts. Real estate is available for purchase. Owner is looking to retire.
Annual revenue
1.76 Million
Listed by Pharmacy Consulting Broker Services (PCBS)
Independent Pharmacy
Connecticut
New
Profitable, well established independent pharmacy in Connecticut. Annual sales of over $5.6 Million and filling approximately 35,000 prescriptions per year with an estimated inventory of $400,000. Owner is looking to retire. Net discretionary income in 2025 after fully staffed was $682,000.
Annual revenue
5.6 Million
Listed by Pharmacy Consulting Broker Services (PCBS)
Retail & Compounding Pharmacy
Florida
New
Profitable pharmacy in Western Florida doing both retail and compounding. Annual sales of $1.8 Million and filling 15,000 prescriptions per year with an estimated inventory of $55,000. Net to owner in 2025 after fully staffed was $363,000.
Annual revenue
1.8 Million
Listed by Pharmacy Consulting Broker Services (PCBS)
Retail & Compounding Pharmacy
Florida
New
Highly profitable pharmacy in Western Florida doing both retail and compounding. Annual sales of $2.9 Million and filling 32,000 prescriptions per year with an estimated inventory of $90,000. Net to owner in 2025 after fully staffed was $1.1 Million.
Annual revenue
2.9 Million
Listed by Pharmacy Consulting Broker Services (PCBS)
Long-Term Care Pharmacy
Florida
New
PRIME exits and American HealthCare Capital is proud to exclusively represent an independent retail and LTC pharmacy with a proven track record based in the Tampa Bay area of Florida. This retail and long-term care combination pharmacy has operated successfully for over 11 years, building a loyal customer base. Key points of value include:
Annual revenue
$3,100,000
Listed by American HealthCare Capital (PRIME exits)

Browse by state